Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

Patients vs. Populations: Afib Experts Get Energized Over Quality Metrics & Training

Five electrophysiologists joined Cardiovascular Business editorial advisor Matthew R. Reynolds, MD, SM, for a discussion about how they will deliver quality care to a growing number of atrial fibrillation patients even as the U.S. healthcare system turns its focus from volume to value.

Thumbnail

Are Powerful Tools Reshaping Decision-making in the Cath Lab?

How will the debate over when to use FFR, IVUS and OCT play out?

Thumbnail

Time to Get Ahead of the Curve: Clinical Decision Support Mandate Delayed, Not Dead

Medicare’s postponement of the CDS requirement means more time to implement best practices.

Thumbnail

Do-Better or Do-Over? Cath Lab Safety May Be Ready for a Reboot

Instead of improving fluoroscopy, should interventional cardiologists and radiologists be focusing on change?

Thumbnail

Goal Reversal? Study Suggests Echocardiography Could Have an Underuse Problem

ASE says new data may be a “wake-up call” to recognize the value of echocardiography.  

Noted cardiologist Jagat Narula receives SCCT award

Jagat Narula, MD, PhD, received the Arthur S. Agatston Cardiovascular Disease Prevention award from the Society of Cardiovascular Computed Tomography (SCCT).

Edwards' Surgical Heart Valve Innovations Demonstrate Positive Patient Benefits

BALTIMORE, May 17, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced positive clinical trial results on two of its advanced innovations in surgical heart valves for the treatment of people with aortic valve disease. Data from three studies—COMMENCE, TRANSFORM and FOUNDATION—were presented as part of the late-breaking sessions at the American Association for Thoracic Surgery's (AATS) 96th annual meeting.  

First-ever pediatric feasibility study results set stage for clinical trial of world’s first bioabsorbable heart valve-enabling Endogenous Tissue Restoration

12-month follow-up data on bioabsorbable technology presented today at annual meeting of American Association for Thoracic Surgery.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.